Aurora Therapeutics
Cambridge
About Aurora Therapeutics
Aurora Therapeutics is reimagining how personalized gene-editing medications are created and approved for patients with rare diseases.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 11 – 50
- Total funding: $16.0M
- Funding stage: Seed
- Last round: Seed (Jan 2026)
- Website: auroratherapeutics.io
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/aurora-therapeutics-27082 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.